# Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma

> **NCT00147875** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Cologne** · enrollment: 60 (actual)

## Conditions studied

- Hodgkin's Disease

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Vinblastine
- **DRUG:** Doxorubicin (Adriamycin)
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00147875
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-07
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-09-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00147875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00147875, "Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00147875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*